Penetration of GSK1322322 into Epithelial Lining Fluid and Alveolar Macrophages as Determined by Bronchoalveolar Lavage

Effect of H2Blockade and Food on Single-Dose Pharmacokinetics of GSK1322322, a Peptide Deformylase Inhibitor Antibacterial

(2013) Odin J. Naderer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Analysis of the Antibacterial Activity of a Novel Peptide Deformylase Inhibitor, GSK1322322

(2013) Karen O'Dwyer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Single-Dose Safety, Tolerability, and Pharmacokinetics of the Antibiotic GSK1322322, a Novel Peptide Deformylase Inhibitor

(2013) Odin J. Naderer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: a randomized placebo-controlled study

(2013) O. J. Naderer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitor

(2013) Odin J. Naderer et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The Future of Antibiotics and Resistance

(2013) Brad Spellberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibiotics in development targeting protein synthesis

(2011) Joyce A. Sutcliffe   Annals of the New York Academy of Sciences

Zanamivir Pharmacokinetics and Pulmonary Penetration into Epithelial Lining Fluid following Intravenous or Oral Inhaled Administration to Healthy Adult Subjects

(2011) Mark J. Shelton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid

(2011) Keith A. Rodvold et al.   CLINICAL PHARMACOKINETICS

Discovery research: the scientific challenge of finding new antibiotics

(2011) D. M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Determination of Disk Diffusion and MIC Quality Control Ranges for GSK1322322, a Novel Peptide Deformylase Inhibitor

(2011) James E. Ross et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Pharmacokinetic‐Pharmacodynamic Considerations in the Design of Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia Studies: Look before You Leap!

(2010) Paul G. Ambrose et al.   CLINICAL INFECTIOUS DISEASES